| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |